Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial) - Dietz,A.; Rudat,V.; Dreyhaupt,J. (Eur Arch Otorhinolaryngol, 2009)